Skip to content

TRIO: Does targeted rehabilitation improve outcomes after stroke?

TRIO: Does targeted upper limb rehabilitation improve upper limb function and quality of life after stroke?

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000755932
Acronym
TRIO
Enrollment
192
Registered
2011-07-19
Start date
2012-03-26
Completion date
2015-10-29
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Stroke is a leading cause of adult disability. In this project a team of clinicians and scientists will evaluate the benefits of a new process for prescribing rehabilitation after stroke, called “Targeted Rehabilitation, Improved Outcomes” (TRIO). The project will implement an algorithm for determining individual patients’ potential for recovering hand and arm movement, and setting appropriate rehabilitation goals. This algorithm uses a combination of simple bedside tests, neurophysiology and neuroimaging, to measure the amount of damage to key pathways in the brain. The research team will evaluate the benefits for patient outcomes of using this algorithm as part of rehabilitation prescription.

Interventions

The prognosis group will have a number of measures made, to predict their potential for recovering hand and arm function after stroke. These measures include simple bedside tests of movement, neurophysiological and neuroimaging measures. The simple beside measures of hand and arm strength will be made within 1 week of stroke. The neurophysiological measures involve using transcranial magnetic stimulation to test the pathways from the movement area of the brain to the weak arm muscles. These mea

The prognosis group will have a number of measures made, to predict their potential for recovering hand and arm function after stroke. These measures include simple bedside tests of movement, neurophysiological and neuroimaging measures. The simple beside measures of hand and arm strength will be made within 1 week of stroke. The neurophysiological measures involve using transcranial magnetic stimulation to test the pathways from the movement area of the brain to the weak arm muscles. These measures will be made within 2 weeks of stroke. The neuroimaging measures involve a short magnetic resonance imaging (MRI) scan, which will take place within 2 weeks of stroke. This information will be provided to therapy teams and to the patients, to guide rehabilitation planning and goal-setting. Standard rehabilitation therapies will be provided, though the intensity and duration of these therapies may be modified by prognosis information.

Sponsors

University of Auckland
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Other
Primary purpose
Diagnosis
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Over 18 years of age Unilateral upper limb weakness as a result of stroke

Exclusion criteria

Cerebellar stroke Severe cognitive or communication impairment that precludes informed consent Contraindications to magnetic resonance imaging or transcranial magnetic stimulation

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 27, 2026